Pfizer says effectiveness of COVID antiviral pill is 'beyond our wildest dreams'


A pill to treat COVID-19 from Pfizer significantly cut the risk of hospitalization and death in a clinical trial, the company has announced.
Pfizer said Friday its pill to treat COVID-19, Paxlovid, in a clinical trial was shown to reduce the risk of hospitalization or death by 89 percent when it was given within three days of the onset of symptoms, The New York Times reports. The trial consisted of participants "who are at high risk of progressing to severe illness," Pfizer said, and there were no deaths among the group treated with Paxlovid compared to 10 deaths in the placebo group, per ABC News.
Pfizer CEO Albert Bourla described the news as a "real game-changer," adding the data suggests the pill "has the potential to save patients' lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations." Pfizer executive Annaliesa Anderson also told The New York Times the "results are really beyond our wildest dreams."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
At the same time, Nahid Bhadelia, founding director of the Center for Emerging Infectious Diseases Policy & Research, noted to Stat News, "The promise of oral antivirals will only be recognized if they're available at your local pharmacy, and you can afford it, and you can get the test that tells you that you're positive for COVID, so you can actually take advantage of this drug. So, the promise is there, but the rest of the pieces need to come together."
The news comes one day after Britain on Thursday became the first country to authorize an oral antiviral pill to treat COVID-19 from Merck. Merck has applied for FDA authorization in the U.S., which could come this year, according to ABC News. Pfizer said Friday it will submit its data to the Food and Drug Administration "as soon as possible," and Bourla told CNBC the company will likely do so before Thanksgiving.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Trump taps Fox News' Pirro for DC attorney post
speed read The president has named Fox News host Jeanine Pirro to be the top federal prosecutor for Washington, replacing acting US Attorney Ed Martin
-
Trump, UK's Starmer outline first post-tariff deal
speed read President Donald Trump and British Prime Minister Kier Starmer struck a 'historic' agreement to eliminate some of the former's imposed tariffs
-
Prevost elected first US pope, becomes Leo XIV
speed read Cardinal Robert Francis Prevost is a Chicago native who spent decades living in Peru
-
Sea lion proves animals can keep a beat
speed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammals
Speed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands
-
Novel 'bone collector' caterpillar wears its prey
Speed Read Hawaiian scientists discover a carnivorous caterpillar that decorates its shell with the body parts of dead insects
-
Scientists find hint of alien life on distant world
Speed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
-
Katy Perry, Gayle King visit space on Bezos rocket
Speed Read Six well-known women went into lower orbit for 11 minutes
-
Scientists map miles of wiring in mouse brain
Speed Read Researchers have created the 'largest and most detailed wiring diagram of a mammalian brain to date,' said Nature
-
Scientists genetically revive extinct 'dire wolves'
Speed Read A 'de-extinction' company has revived the species made popular by HBO's 'Game of Thrones'
-
Dark energy may not doom the universe, data suggests
Speed Read The dark energy pushing the universe apart appears to be weakening